Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Clinical trial reveals genetic fault that reduces the effectiveness of leukemia treatment

    ... they respond to treatment. The findings come from a clinical trial led by the University of Birmingham that examined whether survival ...

    Research Article last updated 09/29/2017 - 10:32am.

  2. Foundation Update - November 2016

    ... On September 24, the AAMDSIF Patient Advisory Council on Clinical Trials (PACCT+) members gathered in Arlington, Virginia for an ... members and learn from two experts about clinical trial design and the state of current MDS research. PACCT+ is a two-year ...

    Article last updated 10/09/2017 - 2:48pm.

  3. Foundation Update - July 2017

    ... June 17, the AAMDSIF Patient Advisory Council on Clinical Trials (PACCT+) members met in Arlington, Virginia for the second ... committee members and learning from two experts about clinical trial design and the state of current MDS research. Learn more ...

    Article last updated 10/09/2017 - 2:42pm.

  4. Updates from John and Isabella!

    ... in this immediate post-transplant period. The clinical trial you’re now part of since arriving here in a caregiver role - how ...

    Patient Chronicle last updated 10/12/2017 - 1:01pm.

  5. Foundation Update - February 2017

    ... as well as director of the Division of Translational/ Clinical Research . Read Dr. List's comments on recent discoveries in ... transplant, drug therapy or involvement in a clinical trial – their image will appear on those web pages as well. Our goal is ...

    Article last updated 10/09/2017 - 2:40pm.

  6. Gemtuzumab Receives New FDA Approval for Acute Myeloid Leukemia

    ... initially successful treatment. However, confirmatory clinical trials showed that the drug did not improve survival and was linked ... of the toxic payload into the cells. In the clinical trial that led to the new approval of gemtuzumab as part of induction ...

    Research Article last updated 10/03/2017 - 12:56pm.

  7. New AML drugs to accelerate genetic testing

    ... AML, MDS and MPN update: Dr David Steensma talks about the clinical implications of important new data sets ... final issue of our brief 3-part tour of new clinical trial findings and treatment strategies in hematologic cancers, we visit Dr ...

    Article last updated 09/25/2017 - 9:32am.

  8. Foundation Update - September 2017

    ... leukemia, ibrutinib's approval came after a randomized clinical trial in which almost half the participants treated with the drug showed a ...

    Article last updated 09/12/2017 - 7:14am.

  9. A call for action: Increasing enrollment of untreated patients with higher-risk myelodysplastic syndromes in first-line clinical trials.

    ... azacitidine , prolonged survival in a large randomized trial. However, multiple real-life and registry analyses have demonstrated ... not been replicated in population-based studies or in other clinical trials using azacitidine monotherapy arms. Herein, we critically ...

    Research Article last updated 09/11/2017 - 9:04am.

  10. FDA approves first drug to treat GVHD

    ... The agency’s approval was based on a nonrandomized clinical trial in which nearly half of patients treated with ibrutinib had significant ...

    Article last updated 08/29/2017 - 7:55am.